Mortality in the US Populations With Monoclonal Gammopathy of Undetermined Significance

JAMA Oncol. 2023 Sep 1;9(9):1293-1295. doi: 10.1001/jamaoncol.2023.2278.
No abstract available

Plain language summary

This cohort study analyzes a nationally representative sample with a screening test for monoclonal gammopathy of undetermined significance (MGUS) to evaluate overall survival of populations with MGUS compared with those without MGUS among the general population in the US.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Disease Progression
  • Humans
  • Monoclonal Gammopathy of Undetermined Significance* / epidemiology
  • Multiple Myeloma*